Latest California Healthline Stories
Drug Industry Spent Millions To Squelch Talk About High Drug Prices
Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.
If Your Insurer Covers Few Therapists, Is That Really Mental Health Parity?
Behavioral care was at least four times more likely to be out-of-network than medical or surgical care, an analysis by Milliman shows.
Stopping Opioid Addiction At One Key Source: The Hospital
Based on research conducted at the University of Michigan’s medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
Your Plumber Offers A Money-Back Guarantee. Should Your Doctor?
Even though consumers don’t expect to pay for faulty service or goods, they are often forced to pay for bad health care. But a small number of hospitals and doctors are seeking to change that practice.
CVS-Aetna Merger A Bid To Bring Down Costs, Gain Competitive Edge
What will the mega-merger mean for consumers and the health care industry? Senior correspondent Chad Terhune offers insight.
Whistleblower: Medicaid Managed-Care Firm Improperly Denied Care To Thousands
An explosive report prepared by a SynerMed executive alleges the California firm, which oversaw care for 1.2 million patients, fabricated documents and violated state and federal regulations for years. The state says it left low-income patients on Medicaid managed care in “imminent danger.”
Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
University Was Tipped Off To Possible Unauthorized Trials Of Herpes Vaccine
Southern Illinois University has concluded its researcher violated university rules and U.S. law.
Doctors Make Big Money Testing Urine For Drugs, Then Ignore Abnormal Results
Medicare and insurers struggle to oversee a booming business in testing urine samples. In some cases, pain doctors’ lack of follow-through can turn fatal.
Heated And Deep-Pocketed Battle Erupts Over 340B Drug Discount Program
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.